Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.

about

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.

Item

http://www.wikidata.org/entity/Q52603881

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@en

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@nl

type

Item

label

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@en

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@nl

prefLabel

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@en

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@nl

P1476

Impact of age on excess risk o ...... amilial hypercholesterolaemia.

@en

P2093

Ivar S Kristiansen

http://www.w3.org/2001/XMLSchema#string

Kirsten Bjørklund Holven

http://www.w3.org/2001/XMLSchema#string

Leiv Ose

http://www.w3.org/2001/XMLSchema#string

Liv J Mundal

http://www.w3.org/2001/XMLSchema#string

Randi Marie Selmer

http://www.w3.org/2001/XMLSchema#string

Torbjorn Wisloff

http://www.w3.org/2001/XMLSchema#string

Trond P Leren

http://www.w3.org/2001/XMLSchema#string

P2860

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

P31

scholarly article

P356

10.1136/HEARTJNL-2017-312706

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29622598

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

6161660

http://www.w3.org/2001/XMLSchema#string